VOMITING INTESTINAL GAS CONSTIPATION DIARRHEA TABLE 1 CAUSES OF DIARRHEA GASTROINTESTINAL TRACT WALL DISORDERS...
|
|
- Arlene Singleton
- 5 years ago
- Views:
Transcription
1 CHAPTER ONE: INTRODUCTION.1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THE STUDY... 1 INTENDED AUDIENCE... 1 SCOPE OF REPORT... 2 METHODOLOGY AND INFORMATION SOURCES... 2 ANALYST CREDENTIALS... 3 RELATED BCC REPORTS... 3 BCC ONLINE SERVICES... 4 DISCLAIMER... 4 CHAPTER TWO: EXECUTIVE SUMMARY... 5 EXECUTIVE SUMMARY... 5 SUMMARY TABLE GLOBAL PRESCRIPTION AND OTC GASTROINTESTINAL DISORDER TREATMENT MARKET, THROUGH 2014 ($ MILLIONS)... 6 SUMMARY FIGURE GLOBAL PRESCRIPTION AND OTC GASTROINTESTINAL DISORDER TREATMENT MARKET, ($ MILLIONS)... 6 CHAPTER THREE: INDUSTRY OVERVIEW... 7 STRUCTURE AND FUNCTION OF THE GASTROINTESTINAL SYSTEM... 7 STRUCTURE AND FUNCTION (CONTINUED)... 8 INGESTION AND PROPULSION OF FOOD... 9 Mouth... 9 Pharynx... 9 Esophagus DIGESTION AND ABSORPTION Mouth Stomach Small Intestines Physiology of Digestion Physiology of Digestion (Continued) ELIMINATION Large Intestine LIVER, BILIARY TRACT AND PANCREAS LIVER BILIARY TRACT Bilirubin Metabolism PANCREAS GASTROINTESTINAL TRACT DISORDERS DYSPHAGIA Dysphagia (Continued) ESOPHAGEAL AND ABDOMINAL PAIN... 17
2 VOMITING INTESTINAL GAS CONSTIPATION DIARRHEA TABLE 1 CAUSES OF DIARRHEA GASTROINTESTINAL TRACT WALL DISORDERS GASTRITIS TABLE 2 COMMON CAUSES OF GASTRITIS GASTROENTERITIS PEPTIC ULCER DISEASE Peptic Ulcer Disease (Continued) GASTRIC ULCERS DUODENAL ULCERS INFLAMMATORY BOWEL DISEASE ULCERATIVE COLITIS CROHN S DISEASE ENTEROCOLITIS DIVERTICULAR DISEASE GASTROINTESTINAL TRACT MOTILITY DISORDERS IRRITABLE BOWEL SYNDROME INTESTINAL OBSTRUCTION GASTROINTESTINAL MALABSORPTION DISORDERS CELIAC DISEASE TROPICAL SPRUE CANCERS OF THE GASTROINTESTINAL TRACT ESOPHAGEAL CANCER GASTRIC CANCER LIVER CANCER PANCREATIC CANCER SMALL INTESTINAL CANCER COLONIC POLYPS AND COLON CANCER Colonic Polyps and (Continued) U.S. DEMOGRAPHICS TABLE 3 U.S. ESTIMATED INCIDENCE/PREVALENCE/MORTALITY OF SELECTED GASTROINTESTINAL CONDITIONS TABLE 4 U.S. POPULATION BY SELECTED AGE GROUPS, 2009 AND 2014 (THOUSANDS) FIGURE 1 U.S. POPULATION BY SELECTED AGE GROUPS, 2009 AND 2014 (THOUSANDS) FIGURE 2 U.S. POPULATION SELECTED AGE GROUPS BY PERCENT OF TOTAL POPULATION, 2009 AND 2014 (%) PILL-SIZED VIDEO CAMERA PILLCAM ESO SMARTPILL... 42
3 RADIO FREQUENCY IDENTIFICATION TECHNOLOGY IPHONE APPLICATION ENTERIC NERVOUS SYSTEM INSURANCE COVERAGE MONOCLONAL ANTIBODIES WYETH IN SUIT WITH STATES GENERIC INFLUENCE BRANDED VS OTC PROTON PUMP INHIBITORS MAIL ORDER TRENDS MAIL ORDER TRENDS (CONTINUED) CHAPTER FOUR: PRESCRIPTION PRODUCT SEGMENTS BY TYPE ANTIDIARRHEALS SYSTEMICALLY ACTING ANTIDIARRHEALS OPIUM PRODUCTS TABLE 5 MARKETED ANTIDIARRHEAL PRODUCTS MARKET SIZE AND GROWTH TABLE 6 GLOBAL PRESCRIPTION ANTIDIARRHEAL MARKET, BY REGION, THROUGH 2014 ($ MILLIONS) FIGURE 3 GLOBAL PRESCRIPTION ANTIDIARRHEAL MARKET, BY REGION, THROUGH 2014 ($ MILLIONS) COMPETITIVE STRUCTURE AND MARKET SHARE TABLE 7 GLOBAL PRESCRIPTION ANTIDIARRHEAL REVENUES AND MARKET SHARE LEVELS, BY MANUFACTURER, 2009 ($ MILLIONS/%) FIGURE 4 GLOBAL PRESCRIPTION ANTIDIARRHEAL REVENUES, 2009 ($ MILLIONS) ANTIEMETICS LOCALLY ACTING ANTIEMETICS CENTRALLY ACTING ANTIEMETICS ANTIDOPAMINERGICS Antidopaminergics (Continued) ANTICHOLINERGICS MISCELLANEOUS ANTIEMETICS Miscellaneous Antiemetics (Continued) Miscellaneous Antiemetics (Continued) TABLE 8 MARKETED ANTIEMETIC PRODUCTS TABLE 8 (CONTINUED) MARKET SIZE AND GROWTH TABLE 9 GLOBAL PRESCRIPTION ANTIEMETIC MARKET BY REGION, THROUGH 2014 ($ MILLIONS) FIGURE 5 GLOBAL PRESCRIPTION ANTIEMETIC MARKET BY REGION, ($ MILLIONS) COMPETITIVE STRUCTURE AND MARKET SHARE... 62
4 TABLE 10 GLOBAL PRESCRIPTION ANTIEMETIC REVENUES AND MARKET SHARE BY MANUFACTURER, 2009 ($ MILLIONS/%) FIGURE 6 GLOBAL PRESCRIPTION ANTIEMETICS REVENUES BY MANUFACTURER, 2009 ($ MILLIONS) GASTROINTESTINAL CANCER TREATMENTS GASTROINTESTINAL CANCER (CONTINUED) GASTROINTESTINAL CANCER (CONTINUED) TABLE 11 MARKETED GASTROINTESTINAL CANCER PRODUCTS MARKET SIZE AND GROWTH TABLE 12 GLOBAL PRESCRIPTION GASTROINTESTINAL CANCER DRUG MARKET BY REGION, THROUGH 2014 ($ MILLIONS) FIGURE 7 GLOBAL PRESCRIPTION GASTROINTESTINAL CANCER DRUG MARKET BY REGION, ($ MILLIONS) COMPETITIVE STRUCTURE AND MARKET SHARE TABLE 13 GLOBAL PRESCRIPTION GASTROINTESTINAL CANCER DRUG REVENUES AND MARKET SHARE, 2009 ($ MILLIONS/%) FIGURE 8 GLOBAL PRESCRIPTION GASTROINTESTINAL CANCER DRUG REVENUES, 2009 ($ MILLIONS) H2 INHIBITORS H2 INHIBITORS (CONTINUED) H2 INHIBITORS (CONTINUED) H2 INHIBITORS (CONTINUED) TABLE 14 MARKETED H2 INHIBITORS PRODUCTS MARKET SIZE AND GROWTH TABLE 15 GLOBAL PRESCRIPTION H2 INHIBITOR MARKET BY REGION, THROUGH 2014 ($ MILLIONS) FIGURE 9 GLOBAL PRESCRIPTION H2 INHIBITOR MARKET BY REGION, ($ MILLIONS) COMPETITIVE STRUCTURE AND MARKET SHARE TABLE 16 GLOBAL PRESCRIPTION H2 INHIBITOR REVENUES AND MARKET SHARE, 2009 ($ MILLIONS/%) FIGURE 10 GLOBAL PRESCRIPTION H2 INHIBITOR REVENUES, 2009 ($ MILLIONS) LAXATIVES LAXATIVES (CONTINUED) TABLE 17 MARKETED LAXATIVE PRODUCTS MARKET SIZE AND GROWTH TABLE 18 GLOBAL PRESCRIPTION LAXATIVE MARKET BY REGION, THROUGH 2014 ($ MILLIONS) FIGURE 11 GLOBAL PRESCRIPTION LAXATIVE MARKET BY REGION, ($ MILLIONS) COMPETITIVE STRUCTURE AND MARKET SHARE TABLE 19 GLOBAL PRESCRIPTION LAXATIVE REVENUES AND MARKET SHARE, 2009 ($ MILLIONS/%)... 78
5 FIGURE 12 GLOBAL PRESCRIPTION LAXATIVE REVENUES, 2009 ($ MILLIONS) PROTON PUMP INHIBITORS PROTON PUMP INHIBITORS (CONTINUED) PROTON PUMP INHIBITORS (CONTINUED) TABLE 20 MARKETED PROTON PUMP INHIBITOR PRODUCTS MARKET SIZE AND GROWTH TABLE 21 GLOBAL PRESCRIPTION PROTON PUMP INHIBITOR MARKET BY REGION, THROUGH 2014 ($ MILLIONS) FIGURE 13 GLOBAL PRESCRIPTION PROTON PUMP INHIBITOR MARKET BY REGION, ($ MILLIONS) COMPETITIVE STRUCTURE AND MARKET SHARE TABLE 22 GLOBAL PRESCRIPTION PROTON PUMP INHIBITOR REVENUES AND MARKET SHARE BY MANUFACTURER, 2009 ($ MILLIONS/%) FIGURE 14 GLOBAL PRESCRIPTION PROTON PUMP INHIBITOR REVENUES BY MANUFACTURER, 2009 ($ MILLIONS) BOWEL ANTI-INFLAMMATORY BOWEL ANTI-INFLAMMATORY (CONTINUED) BOWEL ANTI-INFLAMMATORY (CONTINUED) TABLE 23 MARKETED BOWEL ANTI-INFLAMMATORY PRODUCTS MARKET SIZE AND GROWTH TABLE 24 GLOBAL PRESCRIPTION BOWEL INFLAMMATORY AGENT MARKET BY REGION, THROUGH 2014 ($ MILLIONS) FIGURE 15 GLOBAL PRESCRIPTION BOWEL INFLAMMATORY AGENT MARKET BY REGION, ($ MILLIONS) COMPETITIVE STRUCTURE AND MARKET SHARE TABLE 25 GLOBAL PRESCRIPTION BOWEL INFLAMMATORY AGENT REVENUES AND MARKET SHARE, 2009 ($ MILLIONS/%) FIGURE 16 GLOBAL PRESCRIPTION BOWEL INFLAMMATORY AGENT REVENUES BY MANUFACTURER, 2009 ($ MILLIONS) OTHER GASTROINTESTINAL PRODUCTS ANTISPASMODICS TABLE 26 MARKETED ANTISPASMODIC PRODUCTS DIGESTANTS GASTRIC ACIDIFIERS PANCREATIC ENZYMES TABLE 27 MARKETED DIGESTANT PRODUCTS EVACUANTS TABLE 28 MARKETED EVACUANTS PRODUCTS MUCOSAL PROTECTANTS TABLE 29 MARKETED MUCOSAL PROTECTANT PRODUCTS PROSTAGLANDINS TABLE 30 MARKETED PROSTAGLANDIN PRODUCTS... 94
6 STIMULANTS TABLE 31 MARKETED STIMULANT PRODUCTS MARKET SIZE AND GROWTH TABLE 32 GLOBAL PRESCRIPTION OTHER GASTROINTESTINAL DRUG MARKET BY REGION, THROUGH 2014 ($ MILLIONS) FIGURE 17 GLOBAL PRESCRIPTION OTHER GASTROINTESTINAL DRUG MARKET BY REGION, ($ MILLIONS) COMPETITIVE STRUCTURE TOTAL GLOBAL PRESCRIPTION GASTROINTESTINAL MARKET SIZE AND GROWTH TABLE 33 GLOBAL PRESCRIPTION GASTROINTESTINAL DISORDER TREATMENT REVENUES BY CATEGORY, THROUGH 2014 ($ MILLIONS) FIGURE 18 GLOBAL PRESCRIPTION GASTROINTESTINAL DISORDER TREATMENT REVENUES BY CATEGORY, ($ MILLIONS) TOTAL U.S. PRESCRIPTION GASTROINTESTINAL COMPETITIVE ANALYSIS TABLE 34 MANUFACTURERS MARKET SHARE OF PRESCRIPTION GASTROINTESTINAL DISORDER TREATMENT REVENUES, (ESTIMATED 2009) FIGURE 19 MANUFACTURERS MARKET SHARE OF PRESCRIPTION GASTROINTESTINAL DISORDER TREATMENT REVENUES, 2009 ESTIMATED (%) CHAPTER FIVE: OTC PRODUCT SEGMENTS BY TYPE ANTACIDS SYSTEMIC ANTACIDS Sodium Bicarbonate NONSYSTEMIC ANTACIDS Calcium Carbonate Aluminum Products Magnesium Products Combination Products TABLE 35 MARKETED OTC ANTACID PRODUCTS TABLE 35 (CONTINUED) MARKET SIZE AND GROWTH TABLE 36 GLOBAL OTC ANTACID MARKET BY REGION, THROUGH 2014 ($ MILLIONS) FIGURE 20 GLOBAL OTC ANTACID MARKET BY REGION, ($ MILLIONS) COMPETITIVE STRUCTURE AND MARKET SHARE TABLE 37 GLOBAL OTC ANTACID REVENUES AND MARKET SHARE BY MANUFACTURER, 2009 ($ MILLIONS/%)
7 FIGURE 21 GLOBAL OTC ANTACID MARKET SHARE BY MANUFACTURER, 2009 (%) LOCALLY ACTING ANTIDIARRHEALS ADSORBENTS INTESTINAL FLORA MODIFIERS TABLE 38 MARKETED OTC ANTIDIARRHEAL PRODUCTS MARKET SIZE AND GROWTH TABLE 39 GLOBAL OTC ANTIDIARRHEALS MARKET BY REGION, THROUGH 2014 ($ MILLIONS) FIGURE 22 GLOBAL OTC ANTIDIARRHEALS MARKET BY REGION, ($ MILLIONS) COMPETITIVE STRUCTURE AND MARKET SHARE TABLE 40 GLOBAL OTC ANTIDIARRHEALS REVENUES BY MANUFACTURER, 2009 ($ MILLIONS/%) FIGURE 23 GLOBAL OTC ANTIDIARRHEALS MARKET SHARE BY MANUFACTURER, 2009 (%) H2 INHIBITORS H2 INHIBITORS (CONTINUED) H2 INHIBITORS (CONTINUED) TABLE 41 MARKETED OTC H2 INHIBITORS PRODUCTS MARKET SIZE AND GROWTH TABLE 42 GLOBAL OTC H2 INHIBITOR MARKET BY REGION, THROUGH 2014 ($ MILLIONS) FIGURE 24 GLOBAL OTC H2 INHIBITOR MARKET BY REGION, ($ MILLIONS) COMPETITIVE STRUCTURE AND MARKET SHARE TABLE 43 GLOBAL OTC H2 INHIBITOR REVENUES AND MARKET SHARE BY MANUFACTURER, 2009 ($ MILLIONS/%) FIGURE 25 GLOBAL OTC H2 INHIBITOR MARKET SHARE BY MANUFACTURER, 2009 (%) PROTON PUMP INHIBITORS OMEPRAZOLE (PRILOSEC, PROCTER & GAMBLE) TABLE 44 MARKETED OTC PROTON PUMP INHIBITOR PRODUCTS MARKET SIZE AND GROWTH TABLE 45 GLOBAL OTC PROTON PUMP INHIBITOR MARKET BY REGION, THROUGH 2014 ($ MILLIONS) FIGURE 26 GLOBAL OTC PROTON PUMP INHIBITOR MARKET BY REGION, ($ MILLIONS) COMPETITIVE STRUCTURE AND MARKET SHARE TABLE 46 GLOBAL OTC PROTON PUMP INHIBITOR REVENUES AND MARKET SHARE BY MANUFACTURER, 2009 ($ MILLIONS/%) FIGURE 27 GLOBAL OTC PROTON PUMP INHIBITOR MARKET SHARE BY MANUFACTURER, 2009 (%)
8 LAXATIVES TABLE 47 MARKETED OTC LAXATIVE PRODUCTS TABLE 47 (CONTINUED) MARKET SIZE AND GROWTH TABLE 48 GLOBAL OTC LAXATIVES MARKET BY REGION, THROUGH 2014 ($ MILLIONS) FIGURE 28 GLOBAL OTC LAXATIVE MARKET BY REGION, ($ MILLIONS) COMPETITIVE STRUCTURE AND MARKET SHARE TABLE 49 GLOBAL OTC LAXATIVE REVENUES AND MARKET SHARE BY MANUFACTURER, 2009 ($ MILLIONS/%) FIGURE 29 GLOBAL OTC LAXATIVE MARKET SHARE BY MANUFACTURER, 2009 (%) TOTAL OTC GASTROINTESTINAL DRUG MARKET SIZE AND GROWTH TABLE 50 GLOBAL OTC GASTROINTESTINAL DISORDER TREATMENT MARKET BY PRODUCT CATEGORY, THROUGH 2014 ($ MILLIONS) FIGURE 30 GLOBAL OTC GASTROINTESTINAL DISORDER TREATMENT MARKET BY PRODUCT CATEGORY, ($ MILLIONS) TOTAL OTC GASTROINTESTINAL DRUG COMPETITIVE ANALYSIS TABLE 51 TOTAL MANUFACTURERS REVENUES AND MARKET SHARE OF OTC GASTROINTESTINAL DISORDER TREATMENTS, ESTIMATED 2009 ($ MILLIONS/%) FIGURE 31 TOTAL MANUFACTURERS MARKET SHARE OF OTC GASTROINTESTINAL DISORDER TREATMENTS, ESTIMATED 2009 (%) RESEARCH AND DEVELOPMENT METOSOLV ODT NEXIUM LOW-DOSE ASPIRIN COMBINATION REZONIC SANVAR TAK-390MR (KAPIDEX) ZENPEP AB ALICAFORSEN APF CROFELEMER HUMIRA LINACLOTIDE METHYLNALTREXONE (MNTX) (RELSTAR) MLN 0002 (VEDOLIZUMAB)
9 ORBEC PROCHYMAL RENZAPRIDE REMICADE REZULAR RIFAXIMAN (XIFAXAN) SUTENT ALICAFORSEN ENEMA DEXTOFISOPAM EKB GTI PUMOSETRAG RDP SORAPRAZAN TALNETANT BL BL TABLE 52 GASTROINTESTINAL DISORDER TREATMENTS IN DEVELOPMENT TABLE 52 (CONTINUED) TABLE 52 (CONTINUED) TABLE 52 (CONTINUED) TABLE 52 (CONTINUED) TABLE 52 (CONTINUED) TABLE 52 (CONTINUED) TOTAL MARKET ANALYSIS TABLE 53 GLOBAL PRESCRIPTION AND OTC GASTROINTESTINAL DISORDER MARKET BY CATEGORY, THROUGH 2014 ($ MILLIONS) FIGURE 32 GLOBAL PRESCRIPTION AND OTC GASTROINTESTINAL DISORDER TREATMENT MARKET BY CATEGORY, ($ MILLIONS) CHAPTER SIX: INDUSTRY PARTICIPANTS BY PRODUCT TYPE TABLE 54 GASTROINTESTINAL DISORDER TREATMENT MANUFACTURERS REVENUES AND MARKET SHARE BY TYPE, 2009 ($ MILLIONS/%) FIGURE 33 GASTROINTESTINAL DISORDER TREATMENT MANUFACTURERS MARKET SHARE BY TYPE, 2009 (%) COMPANY PROFILES ASTRAZENECA History AXCAN PHARMA, INC History CENTOCOR, INC
10 History EISAI, INC History GENENTECH, INC History GLAXOSMITHKLINE Glaxosmithkline (Continued) Glaxosmithkline (Continued) History JOHNSON & JOHNSON History MCNEIL CONSUMER HEALTHCARE History MERCK & CO., INC History NOVARTIS INTERNATIONAL AG History PFIZER, INC History PROCTER & GAMBLE CO History ROCHE History SANOFI-AVENTIS History SALIX PHARMACEUTICALS, LTD History SOLVAY PHARMACEUTICALS History TAKEDA PHARMACEUTICALS NORTH AMERICA History WYETH History APPENDIX: CONTACT INFORMATION FOR GASTROINTESTINAL MARKET PARTICIPANTS M CORP ABBOTT LABORATORIES ABEILLE PHARMA, INC ACAMBIS, PLC ACE BIOSCIENCES A/S AGI THERAPEUTICS, INC ALCHEMIA, LTD ALIZYME, PLC ALLERGAN, INC
11 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC ALTANA PHARMA AG ALVINE PHARMACEUTICALS, INC AMARIN CORP AMGEN, INC ANTIGENICS, INC APOTHECON B.V AP PHARMA, INC ARCO PHARMACEUTICALS ASPHELIA PHARMACEUTICALS, INC ARYX THERAPEUTICS, INC ASTELLAS PHARMA, INC ASTRAZENECA, PLC AXCAN PHARMA, INC BERTEK (MYLAN LABORATORIES INC.) BIOBALANCE, INC BIOGEN IDEC, INC BIOLINERX, LTD BRAINTREE LABORATORIES, INC BRISTOL-MYERS SQUIBB CO CELLDEX THERAPEUTICS, INC CENTOCOR ORTHO BIOTECH, INC CEPHALON, INC CERIMON PHARMA, INC CHEMOCENTRYX, INC CLAVIS PHARMA ASA COSMO PHARMACEUTICALS SPA CYTOKINE PHARMASCIENCES, INC DEBIOPHARM S.A DOR BIOPHARMA, INC EISAI CO., LTD ELAN CORPORATION, PLC EMD SERONO, INC ENZO EURAND PHARMACEUTICALS, INC EVOKE PHARMA FRESENIUS KABI AG GENENTECH, INC GENZYME GENERAL GLAXOSMITHKLINE, PLC GLAXOSMITHKLINE CONSUMER HEALTHCARE GLENMARK PHARMACEUTICALS, LTD H3 PHARMA, INC HELSINN HEALTHCARE
12 HOFFMAN-LAROCHE, LTD. (ROCHE) HYPERION THERAPEUTICS, INC IMMUCELL CORP ISIS PHARMACEUTICALS. INC JANSSEN PHARMACEUTICA PRODUCTS, LP (JOHNSON & JOHNSON) JOHNSON & JOHNSON LORUS THERAPEUTICS, INC MCNEIL CONSUMER & SPECIALTY PHARMACEUTICALS MEDISCA, INC MERCK & CO., INC MONARCH LABS NABI BIOPHARMACEUTICALS NOVARTIS CORP NPS PHARMACEUTICALS, INC OTSUKA AMERICA PHARMACEUTICAL, INC PFIZER, INC THE PROCTER & GAMBLE CO PRODIGENE, INC PROGENICS PHARMACEUTICALS, INC RAVEN BIOTECHNOLOGIES, INC RELIANT PHARMACEUTICALS, INC ROXANE LABORATORIES, INC SALIX PHARMACEUTICALS, LTD SANOFI-AVENTIS SANTARUS, INC SCHERING AG SCHWARZ PHARMA AG SERONO S.A SHIRE PHARMACEUTICALS GROUP, PLC SOLVAY S.A SUCAMPO PHARMACEUTICALS, INC SWISS AGENCY FOR THERAPEUTIC PRODUCTS (SWISSMEDIC) TAKEDA PHARMACEUTICAL NORTH AMERICA TARGACEPT, INC THERAVANCE, INC UCB PHARMA, INC UNIMED PHARMACEUTICALS, INC PHARMOS PHARMACEUTICALS, INC WATSON PHARMACEUTICALS, INC WYETH (WHITEHALL-ROBINS HEALTHCARE, INC.)
THERAPIES AND BIOMARKERS FOR INFLAMMATORY BOWEL DISEASE
THERAPIES AND BIOMARKERS FOR INFLAMMATORY BOWEL DISEASE PHM125A January 2013 Willem Westra Project Analyst ISBN: 0-89336-715-X BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 866-285-7215,
More informationREGULATORY UPDATES: APPROVAL, DENIALS AND AGREEMENTS REGULATORY UPDATES: APPROVAL, (CONTINUED)... 38
CHAPTER ONE: INTRODUCTION... 1 STUDY OBJECTIVES... 1 REASONS FOR DOING THIS STUDY... 1 INTENDED AUDIENCE... 2 SCOPE OF THE STUDY... 2 METHODOLOGY... 2 INFORMATION SOURCES... 2 ABOUT THE AUTHOR... 3 RELATED
More informationTHYROID HORMONE THERAPY TABLE 21 SHARES OF MANUFACTURERS/DISTRIBUTORS FOR FIGURE 4 SHARES OF MANUFACTURERS/DISTRIBUTORS FOR
CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THIS STUDY... 1 INTENDED AUDIENCE... 1 SCOPE OF REPORT... 2 METHODOLOGY... 2 INFORMATION SOURCES... 2 ANALYST S CREDENTIALS...
More informationCHAPTER ONE: EXECUTIVE SUMMARY
CHAPTER ONE: EXECUTIVE SUMMARY Introduction Scope and Methodology Total Size and Growth of the Market Issues and Trends Affecting Market Leading Competitors CHAPTER TWO: INTRODUCTION AND INDUSTRY TRENDS
More informationGASTRIC CANCER TESTING, TREATMENT AND PREVENTION: TECHNOLOGIES AND GLOBAL MARKETS. HLC174A October Usha Nagavarapu Project Analyst
GASTRIC CANCER TESTING, TREATMENT AND PREVENTION: TECHNOLOGIES AND GLOBAL MARKETS HLC174A October 2015 Usha Nagavarapu Project Analyst ISBN: 1-62296-167-6 BCC Research 49 Walnut Park, Building 2 Wellesley,
More informationCHAPTER THREE: INDUSTRY OVERVIEW... 6 HISTORICAL PERSPECTIVE OF THE MENTAL HEALTH INDUSTRY... 6 HISTORICAL PERSPECTIVE OF THE (CONTINUED)...
CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR STUDY... 1 SCOPE OF STUDY... 1 METHODOLOGY AND INFORMATION SOURCES... 2 ANALYST CREDENTIALS... 2 RELATED BCC REPORTS... 2 DISCLAIMER...
More informationScope and Methodology Size and Growth of the Market Issues and Trends Affecting the Rx-to-OTC Switches Market Leading Competitors
TABLE OF CONTENTS CHAPTER ONE: EXECUTIVE SUMMARY Scope and Methodology Size and Growth of the Market Issues and Trends Affecting the Rx-to-OTC Switches Market Leading Competitors CHAPTER TWO: INTRODUCTION
More informationUS pharmaceutical market: trends, issues, forecast. Doug Long Vice President Industry Relations IMS Health
US pharmaceutical market: trends, issues, forecast Doug Long Vice President Industry Relations IMS Health 2006 Strategic management review The World Pharmaceutical Market All reproduction rights, quotations,
More informationFecal incontinence causes 196 epidemiology 8 treatment 196
Subject Index Achalasia course 93 differential diagnosis 93 esophageal dysphagia 92 95 etiology 92, 93 treatment 93 95 work-up 93 Aminosalicylates, pharmacokinetics and aging effects 36 Antibiotics diarrhea
More informationGLOBAL MARKETS FOR TREATMENT AND DIAGNOSIS OF SEXUALLY TRANSMITTED DISEASES
GLOBAL MARKETS FOR TREATMENT AND DIAGNOSIS OF SEXUALLY TRANSMITTED DISEASES PHM005C January 2013 Peggy Lehr Project Analyst ISBN: 0-89336-646-3 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481
More informationCHAPTER FOUR: MARKET SIZE AND GROWTH SLEEP MEDICATIONS MARKET PRESCRIPTION... 40
CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR STUDY... 1 SCOPE OF STUDY... 1 METHODOLOGY AND INFORMATION SOURCES... 2 ANALYST CREDENTIALS... 2 RELATED BCC REPORTS... 2 BCC
More informationINCRETIN-BASED DRUGS: MARKETS FOR DIABETES THERAPIES AND DEVELOPING TREATMENTS
INCRETIN-BASED DRUGS: MARKETS FOR DIABETES THERAPIES AND DEVELOPING TREATMENTS PHM162A February 2015 Kim Lawson Project Analyst ISBN: 1-62296-047-5 BCC Research 49 Walnut Park, Building 2 Wellesley, MA
More informationGastroenterology. Certification Examination Blueprint. Purpose of the exam
Gastroenterology Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills expected of the certified gastroenterologist
More informationProton Pump Inhibitors. Description. Section: Prescription Drugs Effective Date: July 1, 2014
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.09.01 Subject: Proton Pump Inhibitors Page: 1 of 7 Last Review Date: June 12, 2014 Proton Pump Inhibitors
More informationMEDICINES FOR SMOKING CESSATION: GLOBAL MARKETS. PHM154A September Anand Gijare Project Analyst ISBN:
MEDICINES FOR SMOKING CESSATION: GLOBAL MARKETS PHM154A September 2013 Anand Gijare Project Analyst ISBN: 1-56965-544-8 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 866-285-7215, 781-489-7301
More informationOncology Pipeline Analytics
Oncology Pipeline Analytics Trials, Drug Classes, Indications, Correlations and Strategies Report Brochure O n c o l o g y P i p e l i n e A n a l y t i c s Greystone Research Associates is pleased to
More informationLEARNING RESOURCES. 1. Anatomy: Gross Anatomy of The Liver and Gall Bladder Study from: Essential Moore, 5 th Ed., Pages: DEMO note.
PROBLEM 1 (Hepatitis) 1. Anatomy: Gross Anatomy of The Liver and Gall Bladder Study from: Essential Moore, 5 th Ed., Pages: 158-166 + DEMO 2. Histology: Histology of The Liver and Gall Bladder Study from:
More informationANTITHROMBOTIC/ANTICOAGULANT DRUGS: TECHNOLOGIES AND GLOBAL MARKETS
ANTITHROMBOTIC/ANTICOAGULANT DRUGS: TECHNOLOGIES AND GLOBAL MARKETS PHM119B September 2016 Anuj Pathak Project Analyst ISBN: 1-62296-345-8 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA
More informationBOTANICAL AND PLANT-DERIVED DRUGS: GLOBAL MARKETS
BOTANICAL AND PLANT-DERIVED DRUGS: GLOBAL MARKETS BIO022G August 2015 Kim Lawson Project Analyst ISBN: 1-62296-134-X BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215 (toll-free
More informationINTRAVENOUS (IV) THERAPY AND VEIN ACCESS: GLOBAL MARKETS
INTRAVENOUS (IV) THERAPY AND VEIN ACCESS: GLOBAL MARKETS HLC046C November 2014 Mary C. Patton Project Analyst ISBN: 1-56965-982-6 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215
More informationADULT ENTERAL NUTRITION PARENTERAL NUTRITION U.S. REGULATORY ENVIRONMENT THE INFANT FORMULA ACT OF The 1986 Amendments
CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THE STUDY... 1 SCOPE AND FORMAT... 1 METHODOLOGY AND INFORMATION SOURCES... 2 ANALYST CREDENTIALS... 2 RELATED BCC REPORTS...
More informationProton Pump Inhibitors. Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.50.01 Subject: Proton Pump Inhibitors Page: 1 of 6 Last Review Date: June 24, 2015 Proton Pump Inhibitors
More informationIrritable Bowel Syndrome - Pipeline Review, H2 2016
Report Information More information from: https://www.wiseguyreports.com/reports/752817-irritable-bowel-syndrome-pipeline-review-h2-2016 Irritable Bowel Syndrome - Pipeline Review, H2 2016 Report / Search
More informationPHM029D - Antifungal Drugs: Technologies and Global Markets TABLE OF CONTENTS
TABLE OF CONTENTS CHAPTER 1 INTRODUCTION 1 STUDY GOALS AND OBJECTIVES 1 REASONS FOR DOING THIS STUDY 1 INTENDED AUDIENCE 2 SCOPE OF REPORT 2 METHODOLOGY 2 INFORMATION SOURCES 2 ANALYST CREDENTIALS 3 RELATED
More informationCHAPTER ONE: EXECUTIVE SUMMARY
CHAPTER ONE: EXECUTIVE SUMMARY Introduction Scope and Methodology Size and Growth of the Market Issues and trends Leading Competitors CHAPTER TWO: INTRODUCTION AND OVERVIEW Definition of Pain Magnitude
More informationCANCER VACCINES: TECHNOLOGIES AND GLOBAL MARKETS
CANCER VACCINES: TECHNOLOGIES AND GLOBAL MARKETS PHM173A January 2015 Shalini Shahani Dewan Project Analyst ISBN: 1-62296-008-4 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215
More informationPrevention and Treatment of Prostate Cancer: Technologies and Global Markets March Usha Nagavarapu. Report # PHM113B
Prevention and Treatment of Prostate Cancer: Technologies and Global Markets March 2017 Usha Nagavarapu Report # PHM113B Table of Contents Chapter 1 Introduction... 1 Introduction... 1 Study goals and
More informationCHAPTER THREE: INDUSTRY OVERVIEW... 6 STRUCTURE AND HISTORY OF THE DENTAL INDUSTRY... 6 STRUCTURE AND HISTORY (CONTINUED)... 8
CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THE STUDY... 1 SCOPE OF REPORT... 1 METHODOLOGY... 1 RELATED BCC STUDIES... 2 ANALYST CREDENTIALS... 2 BCC RESEARCH ONLINE
More informationGlobal Irritable Bowel Syndrome (IBS) Market: Trends & Opportunities ( )
Global Irritable Bowel Syndrome (IBS) Market: Trends & Opportunities (2012-17) Scope of the Report The report titled Global Irritable Bowel Syndrome Market: Trends and Opportunities (2012-17) provides
More informationEsophageal Disorders. Gastrointestinal Diseases. Peptic Ulcer Disease. Wireless capsule endoscopy. Diseases of the Small Intestine 7/24/2010
Esophageal Disorders Gastrointestinal Diseases Fernando Vega, MD HIHIM 409 Dysphagia Difficulty Swallowing and passing food from mouth via the esophagus Diagnostic aids: Endoscopy, Barium x ray, Cineradiology,
More informationJAK AND PI3K SIGNALING PATHWAY MARKETS
JAK AND PI3K SIGNALING PATHWAY MARKETS PHM168A April 2014 Shalini Shahani Dewan Project Analyst ISBN: 1-56965-793-9 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215 (toll-free
More informationGI Pharmacology. Dr. Alia Shatanawi 5/4/2018
GI Pharmacology Dr. Alia Shatanawi 5/4/2018 Drugs Used in Gastrointestinal Diseases Drugs used in Peptic Ulcer Diseases. Drugs Stimulating Gastrointestinal Motility &Laxatives. Antidiarrheal Agents. Drugs
More informationDNA VACCINES: TECHNOLOGIES AND GLOBAL MARKETS
DNA VACCINES: TECHNOLOGIES AND GLOBAL MARKETS BIO067B July 2014 Jon Evans Project Analyst ISBN: 1-56965-883-8 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215 (toll-free within
More informationGASTROENTEROLOGY Maintenance of Certification (MOC) Examination Blueprint
GASTROENTEROLOGY Maintenance of Certification (MOC) Examination Blueprint ABIM invites diplomates to help develop the Gastroenterology MOC exam blueprint Based on feedback from physicians that MOC assessments
More informationU.S. AND GLOBAL MARKETS FOR ETHICAL NUTRITION IN HEALTHCARE
U.S. AND GLOBAL MARKETS FOR ETHICAL NUTRITION IN HEALTHCARE FOD029E January 2015 Mary Anne Crandall Project Analyst ISBN: 1-62296-005-X BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215
More informationToGA: Trastuzumab with Standard Chemotherapy for HER2-Positive Advanced Gastric Cancer (GC)
ToGA: Trastuzumab with Standard Chemotherapy for HER2-Positive Advanced Gastric Cancer (GC) For more visit ResearchToPractice.com/5MJC CME INFORMATION OVERVIEW OF ACTIVITY Each year, thousands of clinicians
More informationOperatory Units TABLE 20 SELECT MANUFACTURERS AND DISTRIBUTORS OF DENTAL FURNITURE TABLE 20 (CONTINUED) Cavity Preparation Systems
CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THE STUDY... 1 SCOPE AND FORMAT... 1 METHODOLOGY... 1 RELATED BCC STUDIES... 2 ANALYST CREDENTIALS... 2 BCC ON-LINE SERVICES...
More informationBRIC DIABETES DRUGS MARKET
BRIC DIABETES DRUGS MARKET R e p o r t D e s c r i p t i o n T a b l e o f C o n t e n t s L i s t o f T a b l e s S a m p l e T a b l e s R e l a t e d R e p o r t s A b o u t M a r k e t s a n d M a
More informationInfluenza Vaccination Market Research Report Global Forecast till 2023
Report Information More information from: https://www.marketresearchfuture.com/reports/1621 Influenza Vaccination Market Research Report Global Forecast till 2023 Report / Search Code: MRFR/HC/1090-HCRR
More informationCHAPTER FOUR: UPDATE ON THE AIDS PANDEMIC TABLE 2 MILESTONES IN THE HISTORY OF HIV/AIDS TABLE 2 (CONTINUED) REGIONAL OVERVIEW...
CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THE STUDY... 1 SCOPE OF REPORT... 1 MARKET ANALYSES AND FORECASTS... 2 INTENDED AUDIENCE... 2 INFORMATION SOURCES... 2 ANALYST
More informationJohn Ansell President, John Ansell Consultancy Thame, UK
Rutgers University Monday 29 September 2014 Co Eli Lilly Bristol-Myers Squibb Novo Nordisk Pfizer GlaxoSmithKline Takeda Sanofi Novartis AstraZeneca Roche Otsuka Johnson & Johnson Otsuka Abbott Teva 1
More informationNew Prognostic Markers in Acute Myeloid Leukemia (AML)
New Prognostic Markers in Acute Myeloid Leukemia (AML) For more visit ResearchToPractice.com/5MJCMDSAML CME INFORMATION OVERVIEW OF ACTIVITY Acute myeloid leukemia (AML) and the myelodysplastic syndromes
More informationPharmacology. Drugs that Affect the Gastrointestinal System
Pharmacology Drugs that Affect the Gastrointestinal System Topics Peptic Ulcer Disease Constipation Diarrhea Emesis Digestion Peptic Ulcer Disease Factors that Increase Acidity Factors that Protect Against
More informationNational Digestive Diseases Information Clearinghouse
Gastritis National Digestive Diseases Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What is gastritis? Gastritis is a condition in which the stomach
More informationKenneth Gordon, 1 Kim A. Papp, 2 Kara Creamer Rice, 3 Mona Trivedi, 3 David H. Collier, 3 Greg Kricorian 3
American Academy of Dermatology 75 th Annual Meeting, Orlando, FL; March 3 7, 2017 Poster 4563 Novel Evaluation of Psoriasis Area and Severity Index (PASI) Data: Distribution of PASI Improvements in a
More informationDigestion: Small and Large Intestines Pathology
Digestion: Small and Large Intestines Pathology Dr. Ritamarie Loscalzo Medical Disclaimer: The information in this presentation is not intended to replace a one onone relationship with a qualified health
More informationSickKids Research Institute: List of Funders
SickKids Research Institute: List of Funders 2009-2010 Agency Funding $ Agency Funding $ 3M Pharmaceuticals 2,901 International Council on Amino Acid Science 80,800 Abbott Diagnostics 6,639 International
More informationTABLE OF CONTENTS 1 Table of Contents 2 Introduction 3 Key Marketed Products
TABLE OF CONTENTS 1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 2.1 Epidemiology 2.2 Symptoms 2.3 Etiology 2.4 Pathophysiology 2.5 Co-morbidities and Complications 2.6 Classification
More informationPEDIATRIC PATIENTS, THROUGH 2013 ($ MILLIONS) TABLE 9 SURGICAL COSTS FOR MYRINGOTOMY IN U.S. Adenoidectomy and Tonsillectomy...
CHAPTER ONE: INTRODUCTION... 1 STUDY GOAL AND OBJECTIVES... 1 REASONS FOR DOING THE STUDY... 1 INTENDED AUDIENCE... 2 SCOPE OF REPORT... 2 INFORMATION SOURCES... 2 ANALYST S CREDENTIALS... 3 RELATED BCC
More informationGASTROINTESTINAL AND ANTIEMETIC DRUGS. Submitted by: Shaema M. Ali
GASTROINTESTINAL AND ANTIEMETIC DRUGS Submitted by: Shaema M. Ali GASTROINTESTINAL AND ANTIEMETIC DRUGS by: Shaema M. Ali There are four common medical conditions involving the GI system 1) peptic ulcers
More information2.08 Understand the functions and disorders of the digestive system Essential questions
2.08 Understand the functions and disorders of the digestive system Essential questions What are the functions of the digestive system? How do the functions of chemical and physical digestion interrelate?
More informationSpeaker Introduction
Speaker Introduction Stephen B. Hanauer, MD Professor of Medicine and Clinical Pharmacology University of Chicago Pritzker School of Medicine Chief of Gastroenterology, Hepatology, and Nutrition University
More informationTABLE 7 ADVANTAGES AND DISADVANTAGES OF TOXOID VACCINES SUBUNIT VACCINES Applications of Subunit Vaccines TABLE 8 APPLICATIONS OF
CHAPTER ONE: INTRODUCTION... 1 STUDY OBJECTIVES... 1 REASONS FOR DOING THIS STUDY... 1 INTENDED AUDIENCE... 2 SCOPE OF THE STUDY... 2 METHODOLOGY... 2 INFORMATION SOURCES... 2 ABOUT THE AUTHOR... 3 RELATED
More informationSecond term/
Second term/ 2015-2016 L. 1 Dr Mohammed AL-Zobaidy Learning objectives GIT pharmacology After completing this chapter the student will be able to: Recognise pathophysiological factors implicated in acid-peptic
More informationTHE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES
THE CORPORATE REPUTATION OF PHARMA 2015 THE PERSPECTIVE OF 139 PATIENT GROUPS with an interest in DIABETES PUBLISHED AUGUST 2016 There is growing distrust of pharma in light of several recent and dramatic
More informationREFERENCE CODE GDHC1042FPR PUBLICAT ION DATE DECEMBER 2014 IRRITABLE BOWEL SYNDROME CURRENT AND FUTURE PLAYERS
REFERENCE CODE GDHC1042FPR PUBLICAT ION DATE DECEMBER 2014 IRRITABLE BOWEL SYNDROME Executive Summary Sales of Irritable Bowel Syndrome Market The Irritable Bowel Syndrome (IBS) market in the 7MM (US,
More informationChapter 41. Media Directory. Lower Digestive Tract. Constipation (continued) Constipation
Chapter 41 Drugs for Bowel Disorders and Other Gastrointestinal Conditions Slide 43 Media Directory Tegaserod Animation Upper Saddle River, New Jersey 07458 All rights reserved. Lower Digestive Tract Figure
More informationGastrointestinal System COM MS2 Fall 2017
9/20/2017 Weeks Date Time Title Faculty Week 1 Monday, 9/25/17 8:00-12:00 pm SELF STUDY Monday, 9/25/17 12:00-1:00 pm LUNCH Gastrointestinal System COM 521 - MS2 Fall 2017 Monday, 9/25/17 1:00-2:00 pm
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: capsule_endoscopy_wireless 5/2002 5/2016 5/2017 11/2016 Description of Procedure or Service Wireless capsule
More informationIdentify electrolytes that should be monitored whenever prolonged or severe diarrhea is present
Chapter 35 Drugs Used to Treat Constipation and Diarrhea Learning Objectives State the underlying causes of constipation Explain the meaning of normal bowel habits Cite nine causes of diarrhea Describe
More informationUnderstanding & Alleviating Constipation. Living (Well!) with Gastroparesis Program Warm-Up Class
Understanding & Alleviating Constipation Living (Well!) with Gastroparesis Program Warm-Up Class Please Remember The information presented is for educational purposes only and is in no way intended as
More informationP R E S E N T S Dr. Mufa T. Ghadiali is skilled in all aspects of General Surgery. His General Surgery Services include: General Surgery Advanced Laparoscopic Surgery Surgical Oncology Gastrointestinal
More informationGastroenterology Fellowship Program
Gastroenterology Fellowship Program Outpatient Clinical Rotations I. Overview A. Three Year Continuity Clinic Experience All gastroenterology fellows will be required to have a ½ day continuity clinic
More informationUniversity of Bristol - Explore Bristol Research
Hunt, L., Ben-Shlomo, Y., Whitehouse, M., Porter, M., & Blom, A. (2017). The Main Cause of Death Following Primary Total Hip and Knee Replacement for Osteoarthritis: A Cohort Study of 26,766 Deaths Following
More informationRVD in Patients with High-Risk, Relapsed/Refractory Multiple Myeloma
RVD in Patients with High-Risk, Relapsed/Refractory Multiple Myeloma For more visit ResearchToPractice.com/5MJC CME INFORMATION OVERVIEW OF ACTIVITY Each year, thousands of clinicians and basic scientists
More informationCommon Drug Review Patient Group Input Submissions
Common Drug Review linaclotide (Constella) for irritable bowel syndrome with constipation Patient group input submissions were received from the following patient groups. Those with permission to post
More informationAbstract. Background Gut-selective blockade of lymphocyte trafficking by vedolizumab may constitute effective treatment for ulcerative colitis.
The new england journal of medicine established in 1812 august 22, 213 vol. 369 no. 8 Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis Brian G. Feagan, M.D., Paul Rutgeerts, M.D.,
More informationClinically proven to quickly relieve symptoms of common gastrointestinal disorders. TERRAGASTRO - Good health starts in the gut
Clinically proven to quickly relieve symptoms of common gastrointestinal disorders GASTROINTESTINAL DISEASE Referred to as gastrointestinal diseases, they are common disorders which affect the esophagus,
More informationPrescription Drugs. Medicare & Medicaid Briefings National Health Policy Forum February 22, Jim Hahn Congressional Research Service
Prescription Drugs Medicare & Medicaid Briefings National Health Policy Forum February 22, 2007 Jim Hahn Congressional Research Service Global and US. Prescription Drug Sales, 1998-2005 $700 $600 559 602
More informationGLOBAL MARKETS FOR DIABETES THERAPEUTICS AND DIAGNOSTICS
GLOBAL MARKETS FOR DIABETES THERAPEUTICS AND DIAGNOSTICS HLC029D January 2013 Paul Evers Project Analyst ISBN: 0-89336-238-7 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 866-285-7215, 781-489-7301
More informationCritical Pathways in Breast Cancer Treatment
Critical Pathways in Breast Cancer Treatment Faculty Jenny C Chang, MD Paul E Goss, MD, PhD Kathy D Miller, MD Lawrence N Shulman, MD Dennis J Slamon, MD, PhD Andrew Tutt, MB ChB, PhD Editor Neil Love,
More informationMOVICOL Launched in Japan -The First Polyethylene Glycol Preparation for Chronic Constipation in Japan-
November 29, 2018 EA Pharma Co., Ltd. Eisai Co., Ltd. Mochida Pharmaceutical Co., Ltd. MOVICOL Launched in Japan -The First Polyethylene Glycol Preparation for Chronic Constipation in Japan- EA Pharma
More informationMOVICOL Launched in Japan -The First Polyethylene Glycol Preparation for Chronic Constipation in Japan-
MOVICOL Launched in Japan -The First Polyethylene Glycol Preparation for Chronic Constipation in Japan- This material is an English translation of the press release issued on November 29, 2018 in Japanese,
More informationAstraZeneca and Daiichi Sankyo Launch Proton Pump Inhibitor Nexium 10 mg and 20 mg Granules for Suspension, Sachet, in Japan
AstraZeneca K.K. Daiichi Sankyo Co., Ltd. AstraZeneca and Daiichi Sankyo Launch Proton Pump Inhibitor Nexium 10 mg and 20 mg Granules for Suspension, Sachet, in Japan Osaka and Tokyo, Japan, April 18,
More informationGastrointestinal Pharmacology
Gastrointestinal Pharmacology Jan Kehr Department of Physiology and Pharmacology Gastrointestinal Pharmacology v Background v Peptic disorders v Constipation and Diarrhea v Chronic Bowel Disease Gastrointestinal
More informationIrritable Bowel Syndrome - Pipeline Review, H2 2016
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Irritable Bowel Syndrome - Pipeline Review, H2 2016 Irritable Bowel Syndrome - Pipeline Review, H2 2016 Publication
More informationAmyloidosis & the GI Tract
Amyloidosis & the GI Tract John O. Clarke, M.D. Director, Esophageal Program Clinical Associate Professor of Medicine Stanford University john.clarke@stanford.edu 2017 Topics to cover 1) Patterns of GI
More informationGastrointestinal. Issues in ElderCare. TCHP Education. Consortium. Part of the ElderCare: Healthcare for the Aging Series
TCHP Education Consortium Gastrointestinal Issues in ElderCare Part of the ElderCare: Healthcare for the Aging Series TCHP Education Consortium, 2004, 2007 This educational activity expires December 31,
More informationPhase II Study of Clofarabine for Older Patients with Treatment-Naïve AML
Phase II Study of Clofarabine for Older Patients with Treatment-Naïve AML CME INFORMATION OVERVIEW OF ACTIVITY Acute myeloid leukemia (AML) and the myelodysplastic syndromes (MDS) account for approximately
More informationGiancarlo Comi, M.D. On Behalf of the MS-LAQ-301 (ALLEGRO) Study Group. Assessment of oral laquinimod in preventing progression of Multiple Sclerosis
COMPARISON OF EARLY AND DELAYED ORAL LAQUINIMOD IN PATIENTS WITH RELAPSING- REMITTING MULTIPLE SCLEROSIS: EFFECTS ON DISABILITY PROGRESSION AT 36 MONTHS IN THE ALLEGRO TRIAL Giancarlo Comi, M.D. On Behalf
More informationOESOPHAGUS AND STOMACH CHAIR PERSON : Dr. Othman Al Harbi CO-CHAIR: Prof. Ali Somily
WEEK 1 GASTROINTESTINAL & NUTRITION BLOCK (GNT 223) (Male Group A) Week (1) Starting: 19/11/2017 to 23/11/2017 OESOPHAGUS AND STOMACH 19 November 2017 20 November 2017 8:00-9:00 am 21 November 2017 22
More informationA. Incorrect! Histamine is a secretagogue for stomach acid, but this is not the only correct answer.
Pharmacology - Problem Drill 21: Drugs Used To Treat GI Disorders No. 1 of 10 1. Endogenous secretagogues for stomach acid include: #01 (A) Histamine (B) Gastrin (C) PGE1 (D) A and B (E) A, B and C Histamine
More informationLahey Clinic Internal Medicine Residency Program: Curriculum for Gastroenterology
Lahey Clinic Internal Medicine Residency Program: Curriculum for Gastroenterology Faculty representative: David L. Burns, MD, CNSP Resident representative: Tom Castiglione, MD Revision date: March 6, 2006
More informationOrgan Transplantation Market Research Report- Global Forecast Till 2023
Report Information More information from: https://www.marketresearchfuture.com/reports/915 Organ Transplantation Market Research Report- Global Forecast Till 2023 Report / Search Code: MRFR/HC/0410-HCRR
More informationContraceptives: Technologies and Global Markets
A BCC Research Healthcare Report HLC085A Use this report to: Learn how shifting demographic and sociological factors such as population growth, proportion of young population, and perceptions about family
More information62 HUMIRA (ADALIMUMAB) 62 Forecast assumptions 66 Humira forecast Bibliography 70 LIALDA (MESALAZINE MMX) 71 Lialda forecast
TABLE OF CONTENTS To request sample pages please contact us at getcloser@datamonitorhealthcare.com 8 EXECUTIVE SUMMARY 9 METHODOLOGY AND MARKET DEFINITION 9 Market definition for inflammatory bowel disease
More informationGI update. Common conditions and concerns my patients frequently asked about
GI update Common conditions and concerns my patients frequently asked about Specific conditions I ll try to cover today 1. Colon polyps, colorectal cancer and colonoscopy 2. Crohn s disease 3. Peptic ulcer
More informationVaccine Technologies and Global Markets
A BCC Research Pharmaceutical Report and Global Markets PHM014D Use this report to: Learn about the strengths and weaknesses of each category of human and veterinary vaccine to prevent or treat infectious
More informationTherapeutic Agents for the Gastrointestinal System
Therapeutic Agents for the Gastrointestinal System Chapter 20 1 Form and Function of the Gastrointestinal System There are three main functions of the gastrointestinal (GI) system: Digestion Absorption
More informationVisceral Pain Market Share, Size, Analysis, Growth, Industry Trends and Forecasts to 2024 Hexa Research
Visceral Pain Market Share, Size, Analysis, Growth, Industry Trends and Forecasts to 2024 Hexa Research The global visceral pain market size was estimated at USD 9.51 billion in 2016 and is expected to
More informationTitle: Authors: Journal:
IMPORTANT COPYRIGHT NOTICE: This electronic article is provided to you by courtesy of Ferring Pharmaceuticals. The document is provided for personal usage only. Further reproduction and/or distribution
More informationHCPCS Codes (Alphanumeric, CPT AMA) ICD-9-CM Codes Covered by Medicare Program
HCPCS s (Alphanumeric, CPT AMA) 82272 Blood, occult, by peroxidase activity (e.g., guaiac), qualitative, feces, 1-3 simultaneous determinations, performed for other than colorectal neoplasm screening ICD-9-CM
More informationREFERENCE CODE GDHC518DFR PUBLICAT ION DATE DECEMBER 2014 LINZESS (IRRITABLE BOWEL SYNDROME) - FORECAST AND MARKET ANALYSIS TO 2023
REFERENCE CODE GDHC518DFR PUBLICAT ION DATE DECEMBER 2014 LINZESS (IRRITABLE BOWEL SYNDROME) - Executive Summary The Table below presents the key metrics of Ironwood/Actavis/Almirall/Astellas Linzess for
More informationAppendix K Declarations of Interests
Appendix K Declarations of Interests Ms Theresa Shaw - Chair, Guideline Development Group Chief Executive, Foundation of Nursing Studies (FoNS), London Funding for the 'Developing Practice for Healthy
More informationNCD for Fecal Occult Blood Test
NCD for Fecal Occult Blood Test Applicable CPT Code(s): 82272 Blood, occult, by peroxidase activity (e.g., guaiac), qualitative, feces, 1-3 simultaneous determinations, performed for other than colorectal
More informationGlobal Skin Cancer Diagnosis and Therapeutics Market Research and Forecast
Report Information More information from: https://www.wiseguyreports.com/reports/3186925-global-skin-cancer-diagnosis-and-therapeuticsmarket-research Global Skin Cancer Diagnosis and Therapeutics Market
More informationPOCKET HANDBOOK OF GI PHARMACOTHERAPEUTICS
POCKET HANDBOOK OF GI PHARMACOTHERAPEUTICS CLINICAL GASTROENTEROLOGY GEORGE Y. WU, SERIES EDITOR For other titles published in this series, go to www.springer.com/series/7672 POCKET HANDBOOK OF GI PHARMACOTHERAPEUTICS
More informationSUBSTANCE USE DISORDERS
Mario San Bartolomé, MD, MBA, MRO, FASAM SUBSTANCE USE DISORDERS and the GASTROINTESTINAL TRACT Mario San Bartolome, MD, MBA, MRO, FASAM Medical Director Substance Use Disorders Molina Healthcare, Inc.
More information